Equal-WT
WhaleScore 2.0
?
GLENVIEW CAPITAL MANAGEMENT, LLC
NEW YORK NY
Investment Advisor
Hedge Fund
Billionaires Group
Activist Investor
Glenview Capital Management is based out of New York. Glenview Capital Management is a hedge fund with 6 clients and discretionary assets under management (AUM) of $5,601,586,682 (Form ADV from 2024-08-22). Their last reported 13F filing for Q3 2024 included $5,168,460,595 in managed 13F securities
and a top 10 holdings concentration of 64.49%. Glenview Capital Management's largest holding is CVS Health Corp with shares held of 11,946,799. Whalewisdom has at least 95 13F filings, 38 13D filings, 317 13G filings, and 11 Form 4 filings
Business Description
Glenview's advisory business involves a comprehensive research process to identify investments. Their investment team, structured by industry groups, analyzes past results and forecasts future performance using financial models. They engage in thorough discussions with various sources, including management teams, industry analysts, and competitors, to ensure a thorough understanding of the business, industry, and potential risks.
Glenview's investment committee, comprised of portfolio managers and senior investment professionals, evaluates the risk/return profile of all potential investments. They may also seek to secure appointments for certain individuals to the management or board of directors of portfolio companies, including acquired companies of SPACs sponsored by Glenview. This practice could create conflicts of interest as Glenview personnel may have fiduciary duties to both the portfolio company and its shareholders, potentially leading to actions that may not be in the best interests of the clients.
Investment Strategy
Glenview's investment process centers around deep, fundamental research and individual security selection, primarily within equity and credit-oriented strategies. They focus on assessing the fundamental attractiveness of industries, companies, and securities based on their growth characteristics, profit drivers, competitive dynamics, and financial attributes. This analysis is combined with an absolute valuation discipline focused on economic earnings and recurring cash flow to determine the most attractive securities on a risk/reward basis.
Glenview's research efforts involve gathering, assimilating, and analyzing information about industries and companies. Their investment team is structured by industry groups with relevant experience and analytical frameworks to understand businesses. They perform rigorous financial analysis of past results to identify factors that may influence future performance, and their financial models are thoroughly reviewed and stress-tested to identify potential scenarios. They also engage with management teams, industry analysts, competitors, suppliers, and consultants to gain a comprehensive understanding of the investment landscape.
Owners
- ROBBINS, LAWRENCE, MICHAEL - CEO, PORTFOLIO MANAGER & MANAGER
- RODIN, JOHN, DAVID - CO-PRESIDENT
- RFH MANAGEMENT LLC - MEMBER
- HOROWITZ, MARK, JOSEPH - CO-PRESIDENT, GENERAL COUNSEL AND CHIEF COMPLIANCE OFFICER
- BURKE, MICHAEL, JOHN - CHIEF FINANCIAL OFFICER
- RINC FAMILY PARTNERSHIP LLC - MEMBER Click on the Ownership/Private Fund Data tab for more details.
Known Email Addresses
(Subscription Required)
Other Contact Information
(Subscription Required)
2024-09-30
Top Buys (13F)
Name | % Change |
---|---|
CVS CVS Health Corp | 3.88% |
GPN Global Payments Inc | 2.27% |
EXPE Expedia Group Inc | 1.64% |
DNB Dun & Bradstreet Hol | 1.47% |
DXC DXC Technology Co | 1.21% |
2024-09-30
Top Sells (13F)
Name | % Change |
---|---|
THC Tenet Healthcare Cor | 3.67% |
ALIT Alight Inc | 1.95% |
CNC Centene Corp | 1.87% |
CI Cigna Holding Co | 1.37% |
HCA HCA Healthcare Inc | 1.24% |
2024-09-30
13F Holdings Summary
Name | $ Change |
---|---|
CVS CVS Health Corp | 14.53% |
THC Tenet Healthcare Cor | 8.55% |
GPN Global Payments Inc | 8.21% |
CI Cigna Holding Co | 7.05% |
CTVA Corteva Inc | 5.96% |
2024-09-30
13F Activity
Market Value | $5.17b, Prior: $5.08b |
Inflows (Outflows) as % of Total MV | (-7.4033)% |
New Purchases | 7 stocks |
Added To | 18 stocks |
Sold out of | 9 stocks |
Reduced holdings in | 19 stocks |
Top 10 Holdings % | 64.49% |
Turnover %[1] | 29.09% |
Turnover Alt %[2] | 15.65% |
Time Held Top 20 | 8.7 quarters |
Time Held Top 10 | 9.1 quarters |
Time Held All | 10.67 quarters |
[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.
[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.
2024-09-30
13F Sector Allocation Over Time
limited to past 4 quarters. Subscribe to see all available data
2024-09-30
Analysis
Top 20 equal-weighted holdings. Performance numbers calculated through 2024-09-30